Quarterly report pursuant to Section 13 or 15(d)

Liquidity (Details Narrative)

v3.7.0.1
Liquidity (Details Narrative) - USD ($)
 3 Months Ended
Mar. 29, 2017
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Dec. 31, 2015
Cash   $ 1,249,850 $ 7,367,102 $ 3,476,880 $ 8,039,562
Net cash used in operating activities   867,000      
Working capital deficit   9,600,000      
Net loss before taxes   2,647,643 1,940,806    
Depreciation and amortization expenses   1,519,545 $ 1,213,510    
Amount owed by company for acquisition   5,000,000      
Term loan and line of credit   $ 10,000,000      
Line of credit expire date   Sep. 01, 2018      
Term loans expire date   Sep. 01, 2019      
Prudential [Member]          
Term loans expire date May 15, 2017        
Prudential [Member] | March 29, 2017 [Member]          
Purchase price due for payment   $ 3,000,000      
Prudential [Member] | May 15, 2017 [Member]          
Amount owed by company for acquisition   2,000,000      
MediGain [Member]          
Total purchase price   $ 7,000,000